Related references
Note: Only part of the references are listed.Getting TRAIL back on track for cancer therapy
J. Lemke et al.
CELL DEATH AND DIFFERENTIATION (2014)
Indomethacin Sensitizes TRAIL-Resistant Melanoma Cells to TRAIL-Induced Apoptosis through ROS-Mediated Upregulation of Death Receptor 5 and Downregulation of Survivin
Anfernee Kai-Wing Tse et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Necroptosis
Andreas Linkermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins
Lan Yang et al.
APOPTOSIS (2013)
Mitochondrial superoxide mediates mitochondrial and endoplasmic reticulum dysfunctions in TRAIL-induced apoptosis in Jurkat cells
Toshio Inoue et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Role of Glutathione in Cancer Progression and Chemoresistance
Nicola Traverso et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth
Albert G. Remacle et al.
CANCER RESEARCH (2012)
Oxidative stress, inflammation, and cancer How are they linked?
Simone Reuter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
Jynho Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Interfering with ROS Metabolism in Cancer Cells: The Potential Role of Quercetin
Lara Gibellini et al.
Cancers (2010)
Decoy Methods for Assessing False Positives and False Discovery Rates in Shotgun Proteomics
Guanghui Wang et al.
ANALYTICAL CHEMISTRY (2009)
Oxidative Stress Sensitizes Bladder Cancer Cells to TRAIL Mediated Apoptosis by Down-Regulating Anti-Apoptotic Proteins
Shai J. White-Gilbertson et al.
JOURNAL OF UROLOGY (2009)
Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cells
Dmitri V. Rozanov et al.
MOLECULAR CANCER THERAPEUTICS (2009)
In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway
Ruifen Zhang et al.
APOPTOSIS (2008)
Perinucleolar compartment prevalence is a phenotypic pancancer marker of malignancy
John T. Norton et al.
CANCER (2008)
Quercetin Sensitizes Human Hepatoma Cells to TRAIL-Induced Apoptosis Via Sp1-Mediated DR5 Up-Regulation and Proteasome-Mediated c-FLIPS Down-Regulation
Jin Yeop Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5
Yaqin Zhang et al.
MOLECULAR CANCER RESEARCH (2008)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells
Wenshu Chen et al.
CARCINOGENESIS (2007)
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
Takahito Nakahara et al.
CANCER RESEARCH (2007)
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide
Jun Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation
Young-Ho Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry
Joshua E. Elias et al.
NATURE METHODS (2007)
TRAIL signalling: Decisions between life and death
Christina Falschlehner et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors
T. Wenger et al.
CELL DEATH AND DIFFERENTIATION (2006)
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate
Dunyaporn Trachootham et al.
CANCER CELL (2006)
Wnt activation and alternative promoter repression of LEF1 in colon cancer
Tony W. -H. Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Inhibition of mammalian thioredoxin reductase by some flavonoids: Implications for myricetin and quercetin anticancer activity
J Lu et al.
CANCER RESEARCH (2006)
Cytochrome P450 pharmacogenetics and cancer
C Rodriguez-Antona et al.
ONCOGENE (2006)
Effects of oxidative stress on the cardiac myocyte proteome: modifications to peroxiredoxins and small heat shock proteins
TE Cullingford et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
LD Zhang et al.
CANCER GENE THERAPY (2005)
Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo
S Shankar et al.
PROSTATE (2005)
Wnt/β-catenin signaling pathway as novel cancer drug targets
HH Luu et al.
CURRENT CANCER DRUG TARGETS (2004)
TRAIL and its receptors as targets for cancer therapy
H Yagita et al.
CANCER SCIENCE (2004)
Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL
C Voelkel-Johnson et al.
CANCER GENE THERAPY (2002)
TRAIL/Apo-2L: Mechanisms and clinical applications in cancer
RK Srivastava
NEOPLASIA (2001)
Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL
JL Bodmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
